fda warning letters glp-1 november 2025 issued a letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially CVS Caremark decides to remove

While SGLT2-i and GLP-1RA may offer additive or synergistic benefits in reducing BP and cardiovascular risk, current guidelines do not support their role as first-line antihypertensive agents or early adjunctive therapies over established agents such as thiazide diuretics, renin-angiotensin system (RAS) inhibitors, or calcium channel blockers (CCBs)

In the study published by the Jama Network (linked above), it was found that individuals who use GLP-1 drugs have a 9.09 times higher risk of developing pancreatitis

Rabobank: Its way too early to draw conclusions However, Nick Fereday, senior analyst, consumer foods at Rabobank, says we should be careful about making sweeping predictions about the future of the food industry based on preliminary survey data from a relatively small number of GLP-1 drug users

Early intervention makes a difference

11560, Miguel Hidalgo, Ciudad de Mxico, Mxico Reg

2 Based on available evidence, there have been no cases of MTC in humans linked to GLP-1 RAs